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AbStrAct
The aim of the present study was to review the scope of oral 
squamous cell carcinoma (OSCC) research in South Africa, 
including its epidemiology, diagnosis, associated risk factors 
and management. All publications relating to OSCC on the 
South African population were sought. A total of 72 studies 
were included and classified into seven categories; most 
studies were case reports or case series. Risk factors and 
epidemiology were the most investigated categories while 
early detection and diagnosis was the least explored. All the 
main ethnic groups in South Africa were investigated. The 
highest incidence of OSCC in South Africa was reported for 
males of mixed ancestry; there was a male predominance in 
all ethnic groups except for Asians. There is a high prevalence 
of OSCC in younger individuals in comparison with the 
global average. Future research about early detection and 
diagnosis, risk factors, premalignant lesions, management 
and disease progression is suggested. Educational 
programmes are necessary and should include schools 
and tertiary education institutions to reach adolescents and 
young adults.
IntrodUctIon
OSCC ranks amongst the ten most prevalent cancers 
in the world; being associated with high morbidity and 
mortality, it constitutes a public health problem.1,2 As in 
several low and middle-income countries, lack of access 
to oral health care can delay diagnosis of OSCC and 
ultimately decreases survival rates.3
It has been recognised that cancers in the oral cavity and 
oropharynx present wide geographical heterogeneity. In 
South Africa, OSCC derives from a wide geographical 
area.4 OSCC in South Africa is the fifth most common 
cancer in males and the tenth most common cancer 
in females.5 Globally, 6% of oral cancers occur before 
the age of 45; in South Africa, 7.3% of oral cancers 
occur in males in this age group, and 7.8% in females.6 
Lifestyle-related factors like smoking, alcohol, betel nut 
and spices consumption, together with other risk factors 
such as the human papillomavirus (HPV) and persistent 
inflammation in the oral cavity, are associated with the 
aetiology of OSCC.7
The aim of the present paper is to map archived material 
of OSCC in South Africa, including research on its 
epidemiology, aetiology, pathology, diagnosis, associated 
risk factors and management. Results from this review 
could help in defining and refining knowledge and voids 
relating to OSCC research in South Africa.
 
MethodS
This report draws on the Arksey and O’Malley 
methodological framework for scoping reviews.8
Inclusion criteria used to identify potential studies:
1. Anatomical sites: oral, oropharyngeal, or both.
2. Fields of study: premalignant and malignant lesions, 
leukoplakia, eryhthroplakia, combined leukoplakia/
erythroplakia, proliferative verrucous hyperplasia, 
carcinoma-in-situ, verrucous carcinoma, and oral 
squamous cell carcinoma (OSCC). 
3. Study design: laboratory studies, case reports, case 
series, case-control studies, cross-sectional studies 
(including diagnostic accuracy studies), surveys, 
cohort studies, randomised controlled trials (RCTs) 
and other clinical trials, screening studies (using 
Toluidine Blue, chemiluminescence, brush biopsy, 
and tissue fluorescence imaging) and qualitative 
studies. 
4. Population: South African population samples. 
International multicentre studies where one or more 
sites in South Africa were included were also eligible.
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Secondary research (e.g. literature reviews) as well as 
primary studies where the focus was on oral tumours 
of odontogenic origin, salivary gland origin, tumours of 
intra-osseous origin, lymphomas, Kaposi’s sarcoma and 
lesions of melanocyte origin were excluded. Studies on lip 
cancer were also excluded.
Identification of studies for inclusion
A Medline electronic search (accessed via PubMed) 
was performed in October 2012 and updated in January 
2014 and 2017, according to the search terms displayed 
in Table 1. Furthermore, hand searching of reference lists 
of potentially eligible studies was performed during the 
screening and data extraction process. The heads of the 
departments of South African universities in the disciplines 
of Otolaryngology (eight departments), Oral Medicine and 
Periodontology (four departments), Oral Pathology (four 
departments), and Maxillofacial and Oral Surgery (three 
departments) were contacted via email and asked to send 
any additional studies that could have been missed by the 
electronic search. 
selection of studies and extraction of data
Two authors independently reviewed the titles from the 
electronic search results and selected potentially eligible 
studies. Disagreements were resolved by discussion until 
a consensus was reached. The articles sent by the heads 
of departments were screened for their eligibility. 
The following data were extracted from the included articles: 
category (case reports & case series, prevalence & incidence, 
risk factors, early detection and diagnosis; premalignant 
lesions; treatment; and progression of disease); study 
period; study design, sample size, demographics (gender, 
age, ethnicity), aim/objectives and main findings. Missing 
data were described as ‘not reported’. 
reSULtS
The search results and selection process are displayed 
in Figure 1. In summary, four-hundred-and-two articles 
were identified through the Medline search, of which 70 
were identified as potentially eligible during the screening 
process. The 19 emails sent out to heads of departments 
resulted in 46 articles received, of which 22 were included 
as potentially eligible. Scrutiny of the full texts resulted in 72 
studies that met the eligibility criteria. The included studies 
were classified into seven categories, as displayed in Table 
2. Early detection and diagnosis, premalignant lesions and 
disease progression were the least investigated categories. 
The earliest included study included was performed in 1964 
and the latest was performed in 2014. All the extracted data 
were summarised in Tables 3 to 10.
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#23 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR 
#9 OR #10 #11 #12 #13 #14 OR #15 OR #16 OR #17 
OR #18 OR #19 OR #20 OR #21 OR #22
#24 “South Africa” or “Western Cape” or “Northern Cape” or 
“Eastern Cape” or “Southern Cape” or “Kwazulu Natal” 
or Limpopo or Mpumalanga or “Northern Province” or 
“Free State” or Gauteng or Johannesburg or Pretoria 
or Bloemfontein or “Port Elizabeth” or “Cape Town” or 
Durban or Umtata
25 #23 and #24 Figure 1: Flow diagram displaying the search results and selection process.
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Only one of the included studies was a randomised 
controlled trial (RCT). Due to the higher prevalence of 
OSCC among older people, most studies included 
adults and elderly. All main ethnic groups in South 
Africa (Whites, Blacks, Asians and people with Mixed 
ancestry, also referred to as “Coloured”, according to 
the Population Registration Act n.30 of 1950, repealed 
in 199180) have been investigated in relation to OSCC, 
which is important due to the potential influence of 
ethnicity on OSCC. 
Several of the included studies lacked clear objectives; 
amongst those that explicitly stated the objectives, in 
many instances the design of the study was not ideal 
to address the objective. For the studies on risk factors 
for example, most were case series or cross-sectional, 
which offer limited information on the topic. Similarly, for 
the treatment category, only one out of the nine included 
studies was a RCT, which is the most suited design to 
evaluate the efficacy of an intervention.67 
table 2: Categories of OSCC research
category number of studies 
Case reports and case series 12 
Incidence and prevalence 12
Risk factor 21





















2 M adults NR
To describe a case of OSCC 
of anterior mouth floor and 
dorsolateral tongue surface
The dentist should always be aware of changes in the 
oral mucosa, especially in high risk areas of the mouth 










To describe two cases of oral 
leukoplakia
Identification and control of leukoplakia is neces-







1 M elderly NR
To describe a case of 
carcinoma of the gingiva and 
erosive lichen planus
This case emphasises the importance of thorough 
examination of the oral cavity in all patients. For 







1 M adult NR
To describe a case of OSCC of 
the tongue
This case was not typical; although it was associ-
ated with smoking and alcohol use, the patient 







1 F adult NR
To describe a case proliferative 
verrucous leukoplakia
This case had a single area with a white benign 
lesion, which transformed into verrucous carcinoma 
in the absence of traditional risk factors. Clinicians 






1 F adults NR
To describe a case  of OSCC 
of the gingiva related  to teeth 
31 and 41
This unusual case was associated with HIV and 
mimicked a periodontal lesion that could have 









To describe 2 cases OSCC 
in patients with discoid lupus 
erythematosus (DLE).






1 M adults NR
To describe OSCC of anterior 
mouth floor - Radiological 
presentation of spread into 
mandible
Carcinomas in the mandible may result in paraes-
thesia, pathological fracture, bone erosion and 






2 F adults NR
To describe two cases of 
OSCC on the dorso-lateral 
surface of tongue
OSCC have a variety of clinical presentations, and 
is not always associated with traditional risk factors 
of smoking and alcohol consumption. One patient 






1 M adults NR
To describe a case of oral 
submucous fibrosis (OSF) and 
lichenoid interface mucositis
The rare dual lesion could be associated to areca 
nut or spices used by the patient. The tissue reac-







1 M adults Asians**
To describe a case of 
leukoplakia







1 M adults NR
To describe a case of OSCC of 
the anterior mouth floor
Taking biopsy on chronic ulcers is critical to pro-
vide proper treatment, which is guided by the clini-
cal stage of the disease.
*Age refers to either elderly (>65 years old), (adult (18 to 65 years old), adolescent (12 to 18 years old), or child (<12 years old)
**Asians include people from Indian descent • M = male; F = female; NR = not reported
 < 387www.sada.co.za / SADJ Vol 73 No. 6 reSeArch

























To investigate the 
epidemiology of OSCC in 
South Africa from 1997-2001
Prevalence of OSCC in subjects <45 
years was higher in South Africa (7.3% 
for males and 7.8% for females), as 
compared to the global prevalence 
of 6%. The lifetime risk for develop-
ing OSCC and OPSCC is highest for 














To present age standardized 
incidence rates of oral cancer 
in South Africa
From 1988-1991, 3.4% of all can-
cer cases in South Africa were oral 
cancer. The incidence of oral cancer 
in coloured men was the high-
est (13.13 per 100.000) of ethnic 














To present the epidemiology 
of OSCC in South Africa from 
1996-2002
The total number of OSCC over the 
7-year period was 9702, the major-
ity of on the tongue. The male to 
female ratio was 1:3. The incidence 











To determine the incidence of 
oral cancer among the Cape 
Coloured, Cape Malay, Cape 
Indian population
The pattern of oral cancer in Cape 
Coloureds resembles other ethnic 










To determine the prevalence 
of leukoplakia among the 
Malay population of the Cape
Leukoplakia was present in 7.2% of 
the population and smoking played 












To determine cancer incidence 
in the Natal African
In the rural areas, incidence 
decreases with the degree of isolation 
from the urban areas. Results 
suggests that the differences found 













To describe OSCC in the Natal 
African and Indian
Cancer incidence in South Africans 
from Durban (both sexes) is as 
high as for most western countries. 












To investigate the incidence of 
oropharyngeal cancers
Several cases of OSCC were 
included and the prevalence differed 






NR M+F All Asians**
To learn of the current pattern 
of cancer in the descendants 
of people who emigrated from 
India to Durban, South Africa
The main finding was the lower per-
centage of oral and oropharyngeal 
cancers in South African Indians in 















To examine the trends and 
ethnic disparities in oral and 
oro-pharyngeal cancers in 
South Africa during the period 
1992 – 2001
Oro-pharyngeal cancers had higher 
incidence rates for coloured South 











standardized incidence rates 
for intraoral squamous cell 
carcinoma in Blacks on the 
Witwatersrand, South Africa
The age-standardised incidence 
rates of OSCC are relatively high 
for South African Black males and 
low for South African Black females 












To investigate the distribution 
of oral cancer in Africans and 
Whites in Johannesburg
Oral cancer was more prevalent 
among males. More African males 
under 40 years had oral cancer then 
White males
*Age refers to either elderly (>65 years old), (adult (18 to 65 years old), adolescent (12 to 18 years old), or child (<12 years old)
**Asians include people from Indian descent • M = male; F = female; NR = not reported
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To determine the risk of intraoral 
cancer associated with tobacco and 
alcohol
Patients who use tobacco and alcohol had 
ten times more risk to develop oral cancer, 










To determine the effects of cannabis 
smoking on oral soft tissues
Cannabis users presented higher incidence 








105 M+F adults, elderly Black
Detection of Epstein-Barr Virus (EBV) 
in OSCC in a black African population 
sample
There was no evidence for a direct role of 
EBV in the process of malignant transforma-






101 M+F adults Indian
To determine areca nut chewing 
habits in Durban
Areca nut/quid chewing still is a common 
habit among Indians from Durban, South 












To determine the prevalence of betel-
nut chewing and submucous fibrosis 
in Durban
Betel-nut chewing is very prevalent among 
South African Indians (5%) and can result in 
serious health problems, including perma-











To investigate the association of 
areca nut chewing and OSCC in 
South African Indians
Areca nut use (alone or associated with 
tobacco) plays a role in the development of 
OSCC. Eliminating this habit can decrease 






99 M+F adults, elderly Indian
Upper alimentary tract cancer in 
Natal Indians
Cancers of the mouth and oesophagus are 
more prevalent in Indian females than males, 








66 M+F adults, elderly Black
Detection of Human Papilloma Virus 
(HPV) DNA with in situ hybridisation 
in OSCC in a rural black population
HPV is of limited importance in OSC carci-











To investigate the detection of HPV 
in the oropharynx using real time 
polymerase chain reaction













To establish whether there are 
differences in the distribution of oral 
carcinoma between Blacks and 
whites
OSCC was more prevalent in Black subjects 







10 NR NR NR
Is there correlation between ploidy by 
flow cytometry and chromosome 3 
aberration in OSCC
Structural rearrangements involving the 






125 M adults NR
To examine the presence of human 
papilloma virus in sample of South 
African men.
None of the patients who presented oral 








2900 M+F adults, elderly Blacks
To provide recent estimates of 
the relative importance of some 
of the suspected risk factors 
for oesophageal, lung, oral, and 
laryngeal cancers












To investigate whether the human 
papillomavirus is a mutual aetiological 
agent in oral and cervical squamous 
cell carcinoma
The results support the idea of systemic 
susceptibility and infection through a com-
mon agent, such as HPV, which could con-






53 M+F NR NR
To investigate the suitability of 
paraffin-embedded material to predict 
the metastatic potential of OSCC
DNA aneuploidy could predict the meta-
static potential of OSCC through DNA flow 







32 NR NR NR
Immunohistochemical evaluation of 
Fhit protein expression in OSCC
Expression of Fhit protein was altered in 
OSCC, which suggests that the inactivation 






17 NR NR NR
To investigate the role of Fhit in oral 
carcinogenesis
Around 60% of OSCC have no expression 








55 NR adults, elderly Black
To determine p53 mutation profile in 
OSCC of a Black African sample
p53 mutations seem to play a role in oral 
carcinogenesis. The unique distribution of 







120 M+F adults, elderly
Whites,  
Black
To investigate the prevalence of 
Epstein-Barr Virus (EBV) in OSCC in 
young patients
A possible role of EBV virus in the devel-
opment of OSCC cannot be excluded, 








146 M+F adults, elderly Black
To investigate the presence of HPV 
DNA in OSCC from an African 
population sample
HPV is not an etiologic factor in the devel-






110 NR NR Blacks
Correlation between p53 gene 
mutation, p53 protein labelling and 
Proliferating Cell Nuclear Gene 
(PCNA) expression in OSCC
Overexpression of p53 protein was not 
associated with mutations in the p53 gene.
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60 NR NR NR
To evaluate the use of 
Shandon Papsin liquid-based 
oral test (PS LBC)  using 
a novel cytological scoring 
system
The Shandon PS LBC in association with 
transepithelial brush biopsy technique is a 
highly sensitive, specific and economical 
screening test to detect malignancy. The 
proposed oral cytological grading system 










To determine the uptake of an 
oral health screening program
Screening uptake should be improved; the 
strategy used to improve knowledge and 




NR Case Series 50 NR NR NR
To determine the inter-
observer reproducibility of the 
invasive cell grading method 
on OSCC and to correlate this 
with the DNA ploidy status 
and Langerhans cell (LC) 
population
The method for invasive cell grading is 
reproducible; however, there was no cor-
relation between the grading results and 
ploidy status or LC count.
*Age refers to either elderly (>65 years old), (adult (18 to 65 years old), adolescent (12 to 18 years old), or child (<12 years old)
**Asians include people from Indian descent • M = male; F = female; NR = not reported




















To determine the oral health 
status of institutionalized 
elderly Cape Coloureds from 
the Cape Peninsula
White lesions were more prevalent in 








To describe submucous 
fibrosis as a premalignant 
lesion
The epidemiological, clinical and 
cytological aspects of this study 
serve as a diagnostic model for early 














To analyse differences in 
clinicopathological features of 
oral leukoplakia in different
racial groups in the greater 
Johannesburg area of South 
Africa
Black South Africans had more 
non-homogenous leukoplakia (23%) 
than whites (13%); dysplastic oral 
leukoplakia was more prevalent in 
whites (51%) as compared to black 
South Africans (23%). The floor of 
the mouth was the most frequently 
affected site in whites, in black people 
it was the buccal mucosa.






A clinicopathological study of 
premalignant lesions of the 
oral mucosa in a South African 
sample.
Leukoplakia was present predominantly 
in white males and smokers. The peak 
age was the 7th decade. The sites 
most frequently affected were the 










To assess the effects of 
tobacco smoking on cancer 
and cardiovascular disease in 
urban black South Africans.
Risk for cancers of oral cavity/
pharynx was significantly higher 
among current than never-smokers. 
Cigarette consumption is relatively 
low in this population, but the odds 











Oral submucous fibrosis in 
South African Indians: An 
epidemiological study.
Betel nut chewing may cause 
submucous fibrosis, a premalignant 
oral lesion. Programs must target 
Indians to inform on the potential 





Case Series 110 NR NR NR
To evaluate the use of high-
resolution flow cytometry 
on formalin-fixed, paraffin-
embedded tissue of 
leukoplakia from the tongue 
and floor of mouth and to 
correlate the findings with the 
histologic grading.
The ploidy status of premalignant 
lesions, as determined by high-
resolution flow cytometry, may be 
of value in predicting biological 
behaviour and malignant 
transformation of leukoplakia.
*Age refers to either elderly (>65 years old), (adult (18 to 65 years old), adolescent (12 to 18 years old), or child (<12 years old)
**Asians include people from Indian descent • M = male; F = female; NR = not reported
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Case Series 107 NR NR NR
To investigate the incidence of 
metastasis to the submandibular 
gland in patients with head/neck 
squamous cell carcinoma
Submandibular gland metastasis from head 
and neck primary SCC is rare, preservation of 
the ipsilateral submandibular gland during neck 
dissection is oncologically safe, except in case 
of prior surgery or radiotherapy, or primary 








Timing of drain removal following 
head and neck surgery
Drains can be removed safely when
volume falls to <50 ml over 24-h period.
This would result in less morbidity, shorter 









The role of suprahyoid block 
dissection in treating carcinoma of 
the floor of the mouth
Combined with radiotherapy, suprahyoid block 
dissection is effective for treatment of nodal 










To investigate the survival times 
relating to major surgery of oral and 
oropharyngeal carcinoma
Survival at 3 years was 50%, at 5 years was 25%. 
Prognosis and complications were adversely 





20 M+F adults NR
To monitor the dose modifying 
effect of beta-carotene during an 
intensive course of radiation and 
chemotherapy when treating OSCC
Beta-carotene seems to be associated with 










To evaluate the suprahyoid approach 
to treatment of squamous cell 
carcinoma of the base of the tongue
The suprahyoid approach for OSCC of the 
base of the tongue provides good exposure, 






Case Series 8 NR adults NR
To determine whether total 
glossectomy for advanced tongue 
carcinoma is justified
Total glossectomy and postoperative 
radiotherapy is a reasonable option for 
treatment in developing countries, with higher 





Case Series 14 M+F adults NR
To review the use of the buccinator 
myomucosal flap in treatment of a 
case of OSCC
The buccinator myomucosal flap is a good 
option for reconstruction of small and medium 
defects in the oral cavity and oropharynx, with 
low risk failure.
Meyer 201271 2007 Case report 1 F adults NR
To describe the use of the buccal fat 
pad in treatment of a case of OSCC
The pedicled buccal fat pad is reliable for 
small oral defects and oro-antral fistulae. 







2 M adults White
To determine the quality of life of two 
participants who had undergone total 
glosso-laryngectomy 
Total glosso-laryngectomy has a high impact 
on quality of life. Achieving oral communication 
and having a good support structure can help 
improve quality of life.
*Age refers to either elderly (>65 years old), (adult (18 to 65 years old), adolescent (12 to 18 years old), or child (<12 years old)
**Asians include people from Indian descent • M = male; F = female; NR = not reported

















386 NR NR NR
Flow cytometric cellular DNA 
content and lymph-node 
metastasis in OSCC
DNA flow cytometry can help determine 
the risk for metastasis from primary OSCC. 
Metastasis in diploid tumours appear to be 






1 M adult Asians
Discussion of axillary nodal 
metastasis at primary presentation of 
an oropharyngeal primary carcinoma
Although rare, axillary nodal metastasis can occur 
with primary oropharyngeal SCC, reason why the 





Case Series 69 M+F adults NR
To evaluate the incidence of 
submandibular gland metastases in 
cases of oral cavity OSCC
There was an absence of metastasis to the 
submandibular gland in OSCC. Patients 
with early stage OSCC and stage zero neck 
may be candidates for preservation of the 







93 NR NR NR
To investigate the presence of DNA 
ploidy in OSCC
Aneuploid tumour cell lines acquire properties 
that make them capable of invasion and 
metastasis. Diploid primary tumours have 
excellent prognosis with radical surgery.
Hemmer 
199677
NR Case Series 348 NR NR NR
To investigate the relationship 
between flow cytometric DNA 
ploidy and recurrence of OSCC
There is an association between the DNA 
ploidy status of the primary tumour and the 
risk of metastasis. 
Mahomed 
200778
NR Case Series 30 NR NR NR
To determine whether analysis of 
E-cadherin and/or beta-catenin 
expression can aid in the identification 
of OSCCs likely to metastasize
E-cadherin and b-catenin play a key role in 
tumour progression and loss of differentiation 




NR Case Series 32 NR NR NR
To investigate the expression Fhit 
protein in OSCC
For mild/moderate epithelial dysplasia, Fhit 
expression was seen in the superficial layers, 
while severely dysplastic lesions had absence 
of Fhit expression. Fhit expression was 
reduced or absent in 66% of OSCC. 
*Age refers to either elderly (>65 years old), (adult (18 to 65 years old), adolescent (12 to 18 years old), or child (<12 years old)
**Asians include people from Indian descent • M = male; F = female; NR = not reported
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dIScUSSIon
case reports/case series 
The several case reports and case series highlighted 
the importance of the biopsy for abnormal lesions in 
the oral cavity in order to avoid delays in the diagnosis 
of OSCC. Most cases were associated with tobacco 
use and alcohol consumption; however, a few cases of 
OSCC were reported in younger patients in the absence 
of traditional risk factors.12,17 Reports on oral cancer in HIV-
infected and discoid lupus erythematous patients suggest 
a possible role for these conditions in relation to OSCC.14,15 
With the alarming statistics for HIV in South Africa, 12.7% 
of the population is HIV-positive (Government Statistical 
Release 201681); the development of non-AIDS related 
cancers requires further attention.82
Prevalence and incidence
In South Africa, the National Cancer Registry (NCR) 
compiles pathology- based data on cancer in the 
country. The most recent studies on prevalence and 
incidence of oral cancer in South Africa relies on 
data extracted from the NCR database. Globally, oral 
cavity and oropharynx cancers combined account for 
approximately 5% of all cancers in males and 2% of all 
cancers in females; the number of new cases per year 
for both genders is estimated at 310.000.83 In South 
Africa, from 1997-2001, 5% of all cancers in males and 
0.6% of all cancers in females were oral cancers; 0.6% 
and 0.1% were cancers in the oropharynx of males and 
females, respectively.6,21,22
 
The average age standardized incidence rate (ASIR) for oral 
cancer in South Africa from 1996-2001 was 6.2/100.000/
year for men and 1.6/100.000/year for women.6 The 
combined ASIR for both genders was 4.5/100.000/
year29, which is not far from the global average ASIR of 
5.1/100.000/year from the Globocan database.1
Differences among ethnic groups were observed, with 
Coloured males having the highest ASIR for oral cancer 
(10.2/100.000/year), followed by white males (6.9/100.000/
year). Asian women had the highest ASIR amongst 
females (3.4/100.000/year), followed by Coloured and 
White women (both 2.8/100.000/year). The only ethnic 
group where females had higher ASIR than males was the 
Asian group. In subjects under 45 years of age, there was 
no male prevalence.6,21
The majority of oral cancers were diagnosed at the end 
of the sixth decade; the population average age at time of 
diagnosis was 57.8 years.29 In South Africa, the incidence 
of cancers in the oral cavity and oropharynx in males 
(7.3%) and females (7.8%) younger than 45 years is higher 
than the global average (6%).6 Rural populations seem 
to present lower incidence of OSCC as compared with 
urban groups.26 
Oral cancer in Sub-Saharan Africa presents estimated 
mortality rate of 2.8/100.000/year for males and of 
1.0/100.000/year for females for cancer of the lip and oral 
cavity combined.4 A global estimate from the US for the 
5-year relative survival rates for oral cancer is based on the 
clinical stage at diagnosis, with 82% for localized lesions, 
52% for regional lymph node involvement and 27% for 
patients with metastasis.84 It must be pointed out that, 
since only cancers diagnosed histologically are included 
in the NCR, the real burden of oral cancer in South Africa 
can be worse than hitherto reported.21
risk factors
Traditional risk factors such smoking and alcohol consumption 
play a crucial role in the aetiology and pathogenesis of OSCC 
worldwid.7 Globally, oral cancer is more prevalent in males 
and so is smoking; in South Africa the gap among genders 
is large, while 32% of adult men smoke, only 8% of adult 
women are smokers (WHO report 2015).85 
The use of potentially carcinogenic leaf products such as 
areca nut, associated or not with tobacco, adds to the 
complexity of aetiological factors for oral cancer in South 
Africa.4 The habit of chewing areca nut can maybe explain 
the higher prevalence of oral cancer in female South 
Africans of Indian heritage as compared to male Indian 
South Africans.26,35,37 It has been reported that up to 93% of 
adult South African Indian women chew areca nut/quid.37
The potential role of infection with HPV16 and 18 infection 
in OSCC has been investigated worldwide, especially 
in non-smoker younger patients.86,87 Neither HPV nor 
Epstein-Barr virus were associated with OSCC in South 
African subjects.34,40,51 One case series investigated 
alterations in chromosome 3 in relation to OSCC and 
suggested that mutations in the short arm of chromosome 
3 may play a role in the progression of OSCC.42
Globally, low socio economic status has been associated 
with increased odds ratio for development of oral cancer 
(OR up to 2.4), measured as low income, educational level 
and social class.88 Furthermore, a pooled analysis of 16 
studies showed that each portion of fruit or vegetables 
consumed per day decreases the risk for oral cancer (OR 
0.5).89 In a country with much inequity such as South 
Africa, it is surprising that no study has evaluated the role 
of low socio economic status and dietary deficiency for 
oral cancer.
early detection and diagnosis, premalignant lesions 
and disease progression
Despite advances in research and surgical techniques, the 
5-year survival rate for OSCC remains low, with a rough 
estimate of 50%.1 The high morbidity and mortality rates 
emphasize the importance of screening programmes and 
techniques for early detection of malignancy. Although 
exfoliative cytology has been investigated as a pre-
screening alternative,53 the gold standard for diagnosis 
of cancer of the oral cavity and oropharynx remains the 
biopsy.90 Visual examination is still the best screening tool; 
guidelines from the American Dental Association suggest 
that cytology can be useful for patients with suspicious 
lesions that refuse to undergo biopsy.91,92
Leukoplakia is the most common premalignant lesion, the 
overall risk for malignant transformation in oral leukoplakia 
lesions is estimated at 2%. The majority of leukoplakia 
(80%) reported in South Africa affects white subjects.68 Oral 
submucous fibrosis is another recognized premalignant 
condition, with an estimated malignancy transformation rate 
of 3.7%.93 Chewing of areca nut, a common habit among 
Indian and Indian-descendant women, is a significant 
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risk factor for developing oral submucous fibrosis.57,61 
More studies are necessary to better understand the 
carcinogenesis of those premalignant lesions.
It is estimated that in approximately 40% of patients with 
OSCC, the disease progresses through metastases in 
cervical lymph nodes, which worsen prognosis and survival 
rates.94 Submandibular and axillary lymph nodes are rarely 
affected, but should be examined routinely.74,75 Studies 
have suggested that DNA flow cytometry can help identify 
the risk for metastasis in primary OSCC tumours.73,76,77 
Understanding the progression of the disease and its 
metastatic potential can help improve survival rates.
The search for prognostic markers of disease progression 
for OSCC in South African subjects has not yet been 
successful according to studies on the expression 
of E-cadherin and b-catenin.78 Fhit protein has been 
investigated as a potential prognostic factor, since the 
tumour suppressant FHIT gene seems to be inactivated 
in severe dysplastic OSCC lesions.79 Prognosis of tongue 
cancer has been reported as worse when this protein is 
under expressed; however the clinical application of this 
finding is still to be determined.95
Treatment
Surgical techniques for oral cancer treatment have been 
the primary focus of studies on OSCC management in 
South African subjects, highlighting that most lesions are 
diagnosed at a late stage.3 Surgery is the main treatment 
strategy for oral cancer patients worldwide, especially 
in advanced stages. A study from 1992 reported a 50% 
survival rate at 3 years and 25% at 5 years for South 
Africans submitted to major surgery for OSCC.66
Radiotherapy is usually used as an adjunctive treatment 
after surgery for advanced lesions. Chemotherapy has 
not been commonly used for oral cancer treatment, 
however, there has been a trend for its use combined with 
surgery and radiation in advanced or recurrent cases.96 
The use of molecular targeted drugs holds promise on 
less debilitating treatment options for OSCC patients 
worldwide.97
concLUSIonS
OSCC is a significant problem in South Africa, resulting in 
morbidity and mortality. Ethnic and gender variations are 
present, with males of mixed ancestry, having the highest 
incidence rate of OSCC in the country. Smoking and 
alcohol consumption are strong risk factors for OSCC in 
the general population. The prevalence of OSCC in young 
subjects (<45 years) in South Africa is higher than the 
global average and not always associated with traditional 
risk factors. 
Generally, there is a paucity of information on premalignant 
lesions, early diagnosis, traditional and non-traditional 
risk factors, disease progression and management of 
cancers of the oral cavity and oropharynx in South Africa. 
Although there seems to be enough information on the 
epidemiology of OSCC in the country, an underestimation 
of the incidence and prevalence cannot be excluded.
Various studies mention the need for educational 
programmes and public health policies targeting risk 
factors and early identification of lesions, which ideally 
should translate into less invasive treatment, better quality 
of life and lower mortality rates. Educational programmes 
should include schools and tertiary education institutions 
to reach adolescents and young adults. 
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